Article
Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities
28 Sept 2016
Abstract excerpt
Hypersialylation of tumor cell surface proteins along with a marked upregulation of sialyltransferase (ST) activity is a well-established hallmark of cancer. Due to the critical role of STs in tumor growth and progression, ST inhibition has emerged as a potential new antimetastatic strategy for a range of cancers including pancreatic and ovarian. Human STs are divided into subtypes based on their linkage and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
